Galanin (1-13)-Pro-Pro-(Ala-Leu-)₂Ala amide
| Name | Galanin (1-13)-Pro-Pro-(Ala-Leu-)₂Ala amide |
| Category | Galanin and Related Peptides |
| One Letter Code | GWTLNSAGYLLGPPPALALA-NH₂ |
| Three Letter Code | {Gly}{Trp}{Thr}{Leu}{Asn}{Ser}{Ala}{Gly}{Tyr}{Leu}{Leu}{Gly}{Pro}{Pro}{Pro}{Ala}{Leu}{Ala}{Leu}{Ala}-NH₂ |
| Molecular Weight | 1981.330 |
| Application | Alzheimer's DiseaseObesity Research |
| Fitzgerald, Lawrence W., et al. "Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides." Journal of Pharmacology and Experimental Therapeutics 287.2 (1998): 448-456. |
| McDonald, Michael P., et al. "Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions." Journal of Neuroscience 18.13 (1998): 5078-5085. |
| Crawley, Jacqueline N., John K. Robinson, and Tamas Bartfai. "Galanin receptor antagonists M40 and C7 block galanin-induced feeding." Brain research 600.2 (1993): 268-272. |
| Leibowitz, Sarah F., and Taewan Kim. "Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion." Brain research 599.1 (1992): 148-152. |